AJP - Renal Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 283: F944-F951, 2002. First published July 9, 2002; doi:10.1152/ajprenal.00072.2002
0363-6127/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/5/F944    most recent
00072.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rickard, A.
Right arrow Articles by McHowat, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rickard, A.
Right arrow Articles by McHowat, J.
Vol. 283, Issue 5, F944-F951, November 2002

Phospholipid metabolite production in human urothelial cells after protease-activated receptor cleavage

Alice Rickard and Jane McHowat

Department of Pathology, St. Louis University School of Medicine, St. Louis, Missouri 63104

Our laboratory demonstrated previously that stimulation of protease-activated receptors (PARs) on the human urothelial carcinoma cell line RT4 results in activation of a calcium-independent phospholipase A2 (iPLA2), leading to arachidonic acid and PGE2 release. In this study, we have examined PAR activation in normal human urothelial cells (HUR) leading to the production of inflammatory or cytoprotective phospholipid metabolites. The presence of both PAR-1 and PAR-2 on HUR was confirmed by immunoblotting. Stimulation of PAR-1 with thrombin or PAR-2 by tryptase leads to activation of a membrane-associated iPLA2 and the production of platelet-activating factor, arachidonic acid, and PGE2. These responses were all blocked by pretreatment with the iPLA2-selective inhibitor bromoenol lactone. Thus stimulation of PAR-1 or PAR-2 on HUR leads to iPLA2-catalyzed phospholipid hydrolysis, resulting in the production of metabolites that may mediate inflammation or provide cytoprotection to the bladder.

thrombin; tryptase; bromoenol lactone


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
P. Rastogi, A. Rickard, N. Dorokhov, D. J. Klumpp, and J. McHowat
Loss of prostaglandin E2 release from immortalized urothelial cells obtained from interstitial cystitis patient bladders
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1129 - F1135.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Rickard, C. Portell, P. J. Kell, S. M. Vinson, and J. McHowat
Protease-activated receptor stimulation activates a Ca2+-independent phospholipase A2 in bladder microvascular endothelial cells
Am J Physiol Renal Physiol, April 1, 2005; 288(4): F714 - F721.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online